Clinical trials for Gastroesophageal junction adenocarcinoma investigate a range of treatment strategies and patient populations.

16 total trials for this combination

Showing top 10 of 16 trials

Trials

NCT ID	Title	Status	Phase
NCT05334069	Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection	RECRUITING	—
NCT03604991	Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery	SUSPENDED	—
NCT03604991	Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery	SUSPENDED	—
NCT03604991	Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery	SUSPENDED	—
NCT04208958	Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer	COMPLETED	PHASE1/PHASE2
NCT07431281	Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2	RECRUITING	PHASE3
NCT03604991	Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery	SUSPENDED	—
NCT03604991	Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery	SUSPENDED	—
NCT01196390	Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer	COMPLETED	PHASE3
NCT03604991	Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery	SUSPENDED	—

Related Pages

All Gastroesophageal junction adenocarcinoma trials All trials in St. Louis, United States